Alterations of plasma lipid and lipoprotein levels associated with benzodiazepine use The LRC program prevalence study

In a study of white adults from 10 North American Lipid Research Clinics populations, plasma lipid and lipoprotein levels in benzodiazepine (diazepam, chlordiazepoxide, flurazepam) users were compared to both the entire population of non-users and matched control non-users. Significantly higher plas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Atherosclerosis 1981-10, Vol.40 (2), p.159-165
Hauptverfasser: Hunninghake, Donald, Wallace, Robert B., Reiland, Susan, Barrett-Connor, Elizabeth, Wahl, Patricia, Hoover, Joanne, Heiss, Gerardo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 165
container_issue 2
container_start_page 159
container_title Atherosclerosis
container_volume 40
creator Hunninghake, Donald
Wallace, Robert B.
Reiland, Susan
Barrett-Connor, Elizabeth
Wahl, Patricia
Hoover, Joanne
Heiss, Gerardo
description In a study of white adults from 10 North American Lipid Research Clinics populations, plasma lipid and lipoprotein levels in benzodiazepine (diazepam, chlordiazepoxide, flurazepam) users were compared to both the entire population of non-users and matched control non-users. Significantly higher plasma triglyceride and very low density lipoprotein cholesterol levels and by one method of analysis, lower high density lipoprotein cholesterol levels were noted in male benzodiazepine users. No significant differences were noted in total plasma cholesterol or low density lipoprotein cholesterol levels.
doi_str_mv 10.1016/0021-9150(81)90034-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73733374</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0021915081900344</els_id><sourcerecordid>73733374</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-9be5b0847241c3b2c9b2ca714909c878491086f2debd6f4bec30d5277427541a3</originalsourceid><addsrcrecordid>eNp9kFGL1TAQhYMo693Vf6CQJ9GHaqZJm_RFWC66ChcEWZ9DmkzdSNrUJL3L7q-35V720YfhDMw5M8NHyBtgH4FB-4mxGqoOGvZewYeOMS4q8YzsQMmuAqHEc7J7srwklzn_YYwJCeqCXLQACtpmR47XoWAyxccp0zjQOZg8Ghr87B01k9u6OKdY0E804BFDpibnaL0p6Oi9L3e0x-kxOm8ecfYT0iUjvb1Devi5p2vydzLjqng0ASeLNJfFPbwiLwYTMr4-6xX59fXL7f5bdfhx831_fagsb2Spuh6bnikhawGW97Xt1jISRMc6q6QSHTDVDrXD3rWD6NFy5ppaSlHLRoDhV-Tdae_6yN8Fc9GjzxZDMBPGJWvJJedcitUoTkabYs4JBz0nP5r0oIHpDbfeWOqNpVarbrj1Fnt73r_0I7qn0JnvOv98mq_c8Ogx6Wz9hsH5hLZoF_3_D_wDZWqQDg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73733374</pqid></control><display><type>article</type><title>Alterations of plasma lipid and lipoprotein levels associated with benzodiazepine use The LRC program prevalence study</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Hunninghake, Donald ; Wallace, Robert B. ; Reiland, Susan ; Barrett-Connor, Elizabeth ; Wahl, Patricia ; Hoover, Joanne ; Heiss, Gerardo</creator><creatorcontrib>Hunninghake, Donald ; Wallace, Robert B. ; Reiland, Susan ; Barrett-Connor, Elizabeth ; Wahl, Patricia ; Hoover, Joanne ; Heiss, Gerardo ; Medication and hormones working group</creatorcontrib><description>In a study of white adults from 10 North American Lipid Research Clinics populations, plasma lipid and lipoprotein levels in benzodiazepine (diazepam, chlordiazepoxide, flurazepam) users were compared to both the entire population of non-users and matched control non-users. Significantly higher plasma triglyceride and very low density lipoprotein cholesterol levels and by one method of analysis, lower high density lipoprotein cholesterol levels were noted in male benzodiazepine users. No significant differences were noted in total plasma cholesterol or low density lipoprotein cholesterol levels.</description><identifier>ISSN: 0021-9150</identifier><identifier>EISSN: 1879-1484</identifier><identifier>DOI: 10.1016/0021-9150(81)90034-4</identifier><identifier>PMID: 6118165</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Adult ; Age Factors ; Aged ; Anti-Anxiety Agents - pharmacology ; Benzodiazepines ; Chlordiazepoxide ; Cholesterol ; Cholesterol - blood ; Diazepam ; Female ; Flurazepam ; High density lipoprotein ; Humans ; Lipids ; Lipids - blood ; Lipoproteins ; Lipoproteins - blood ; Male ; Middle Aged ; Triglycerides ; Triglycerides - blood ; Very low density lipoprotein</subject><ispartof>Atherosclerosis, 1981-10, Vol.40 (2), p.159-165</ispartof><rights>1981</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-9be5b0847241c3b2c9b2ca714909c878491086f2debd6f4bec30d5277427541a3</citedby><cites>FETCH-LOGICAL-c357t-9be5b0847241c3b2c9b2ca714909c878491086f2debd6f4bec30d5277427541a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0021-9150(81)90034-4$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6118165$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hunninghake, Donald</creatorcontrib><creatorcontrib>Wallace, Robert B.</creatorcontrib><creatorcontrib>Reiland, Susan</creatorcontrib><creatorcontrib>Barrett-Connor, Elizabeth</creatorcontrib><creatorcontrib>Wahl, Patricia</creatorcontrib><creatorcontrib>Hoover, Joanne</creatorcontrib><creatorcontrib>Heiss, Gerardo</creatorcontrib><creatorcontrib>Medication and hormones working group</creatorcontrib><title>Alterations of plasma lipid and lipoprotein levels associated with benzodiazepine use The LRC program prevalence study</title><title>Atherosclerosis</title><addtitle>Atherosclerosis</addtitle><description>In a study of white adults from 10 North American Lipid Research Clinics populations, plasma lipid and lipoprotein levels in benzodiazepine (diazepam, chlordiazepoxide, flurazepam) users were compared to both the entire population of non-users and matched control non-users. Significantly higher plasma triglyceride and very low density lipoprotein cholesterol levels and by one method of analysis, lower high density lipoprotein cholesterol levels were noted in male benzodiazepine users. No significant differences were noted in total plasma cholesterol or low density lipoprotein cholesterol levels.</description><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Anti-Anxiety Agents - pharmacology</subject><subject>Benzodiazepines</subject><subject>Chlordiazepoxide</subject><subject>Cholesterol</subject><subject>Cholesterol - blood</subject><subject>Diazepam</subject><subject>Female</subject><subject>Flurazepam</subject><subject>High density lipoprotein</subject><subject>Humans</subject><subject>Lipids</subject><subject>Lipids - blood</subject><subject>Lipoproteins</subject><subject>Lipoproteins - blood</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Triglycerides</subject><subject>Triglycerides - blood</subject><subject>Very low density lipoprotein</subject><issn>0021-9150</issn><issn>1879-1484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1981</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kFGL1TAQhYMo693Vf6CQJ9GHaqZJm_RFWC66ChcEWZ9DmkzdSNrUJL3L7q-35V720YfhDMw5M8NHyBtgH4FB-4mxGqoOGvZewYeOMS4q8YzsQMmuAqHEc7J7srwklzn_YYwJCeqCXLQACtpmR47XoWAyxccp0zjQOZg8Ghr87B01k9u6OKdY0E804BFDpibnaL0p6Oi9L3e0x-kxOm8ecfYT0iUjvb1Devi5p2vydzLjqng0ASeLNJfFPbwiLwYTMr4-6xX59fXL7f5bdfhx831_fagsb2Spuh6bnikhawGW97Xt1jISRMc6q6QSHTDVDrXD3rWD6NFy5ppaSlHLRoDhV-Tdae_6yN8Fc9GjzxZDMBPGJWvJJedcitUoTkabYs4JBz0nP5r0oIHpDbfeWOqNpVarbrj1Fnt73r_0I7qn0JnvOv98mq_c8Ogx6Wz9hsH5hLZoF_3_D_wDZWqQDg</recordid><startdate>198110</startdate><enddate>198110</enddate><creator>Hunninghake, Donald</creator><creator>Wallace, Robert B.</creator><creator>Reiland, Susan</creator><creator>Barrett-Connor, Elizabeth</creator><creator>Wahl, Patricia</creator><creator>Hoover, Joanne</creator><creator>Heiss, Gerardo</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198110</creationdate><title>Alterations of plasma lipid and lipoprotein levels associated with benzodiazepine use The LRC program prevalence study</title><author>Hunninghake, Donald ; Wallace, Robert B. ; Reiland, Susan ; Barrett-Connor, Elizabeth ; Wahl, Patricia ; Hoover, Joanne ; Heiss, Gerardo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-9be5b0847241c3b2c9b2ca714909c878491086f2debd6f4bec30d5277427541a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1981</creationdate><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Anti-Anxiety Agents - pharmacology</topic><topic>Benzodiazepines</topic><topic>Chlordiazepoxide</topic><topic>Cholesterol</topic><topic>Cholesterol - blood</topic><topic>Diazepam</topic><topic>Female</topic><topic>Flurazepam</topic><topic>High density lipoprotein</topic><topic>Humans</topic><topic>Lipids</topic><topic>Lipids - blood</topic><topic>Lipoproteins</topic><topic>Lipoproteins - blood</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Triglycerides</topic><topic>Triglycerides - blood</topic><topic>Very low density lipoprotein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hunninghake, Donald</creatorcontrib><creatorcontrib>Wallace, Robert B.</creatorcontrib><creatorcontrib>Reiland, Susan</creatorcontrib><creatorcontrib>Barrett-Connor, Elizabeth</creatorcontrib><creatorcontrib>Wahl, Patricia</creatorcontrib><creatorcontrib>Hoover, Joanne</creatorcontrib><creatorcontrib>Heiss, Gerardo</creatorcontrib><creatorcontrib>Medication and hormones working group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Atherosclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hunninghake, Donald</au><au>Wallace, Robert B.</au><au>Reiland, Susan</au><au>Barrett-Connor, Elizabeth</au><au>Wahl, Patricia</au><au>Hoover, Joanne</au><au>Heiss, Gerardo</au><aucorp>Medication and hormones working group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alterations of plasma lipid and lipoprotein levels associated with benzodiazepine use The LRC program prevalence study</atitle><jtitle>Atherosclerosis</jtitle><addtitle>Atherosclerosis</addtitle><date>1981-10</date><risdate>1981</risdate><volume>40</volume><issue>2</issue><spage>159</spage><epage>165</epage><pages>159-165</pages><issn>0021-9150</issn><eissn>1879-1484</eissn><abstract>In a study of white adults from 10 North American Lipid Research Clinics populations, plasma lipid and lipoprotein levels in benzodiazepine (diazepam, chlordiazepoxide, flurazepam) users were compared to both the entire population of non-users and matched control non-users. Significantly higher plasma triglyceride and very low density lipoprotein cholesterol levels and by one method of analysis, lower high density lipoprotein cholesterol levels were noted in male benzodiazepine users. No significant differences were noted in total plasma cholesterol or low density lipoprotein cholesterol levels.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>6118165</pmid><doi>10.1016/0021-9150(81)90034-4</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0021-9150
ispartof Atherosclerosis, 1981-10, Vol.40 (2), p.159-165
issn 0021-9150
1879-1484
language eng
recordid cdi_proquest_miscellaneous_73733374
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adult
Age Factors
Aged
Anti-Anxiety Agents - pharmacology
Benzodiazepines
Chlordiazepoxide
Cholesterol
Cholesterol - blood
Diazepam
Female
Flurazepam
High density lipoprotein
Humans
Lipids
Lipids - blood
Lipoproteins
Lipoproteins - blood
Male
Middle Aged
Triglycerides
Triglycerides - blood
Very low density lipoprotein
title Alterations of plasma lipid and lipoprotein levels associated with benzodiazepine use The LRC program prevalence study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T11%3A36%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alterations%20of%20plasma%20lipid%20and%20lipoprotein%20levels%20associated%20with%20benzodiazepine%20use%20The%20LRC%20program%20prevalence%20study&rft.jtitle=Atherosclerosis&rft.au=Hunninghake,%20Donald&rft.aucorp=Medication%20and%20hormones%20working%20group&rft.date=1981-10&rft.volume=40&rft.issue=2&rft.spage=159&rft.epage=165&rft.pages=159-165&rft.issn=0021-9150&rft.eissn=1879-1484&rft_id=info:doi/10.1016/0021-9150(81)90034-4&rft_dat=%3Cproquest_cross%3E73733374%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73733374&rft_id=info:pmid/6118165&rft_els_id=0021915081900344&rfr_iscdi=true